The news that Walgreens outlined how face-to-face pharmacy and Take Care Clinic programs have been shown to drive better health outcomes further illustrates the fact that human interaction simply does things that mail order cannot.
Kantar Media on Wednesday reported that overall retailer advertising expenditures increased 1.6% and retailer participation in Free Standing Insert coupon promotion pages increased 30.7% over calendar year 2011, versus the corresponding year-ago period.
Higher front-end sales for the month of February helped counter-balance lost revenue from Express Scripts prescriptions, Walgreeens reported Monday. Overall, the drug store chain reported a 1.5% sales increase to $5.9 billion.
Walgreens last week outlined how the company's research has demonstrated the ability of face-to-face pharmacy and Take Care Clinic programs to drive better health outcomes at the IMS Managed Markets Services/Data Niche Conference held here.
There is one key takeaway from Fast Company's naming of Walgreens as one of the industry's most innovative companies — Walgreens wasn't classified under the industry banner of "retailer," but under the industry banner of "health care."
Walgreens and AARP are expanding their relationship with a new retail drug store program that will provide AARP members with exclusive offers and rewards, and includes member and community outreach to promote health and wellness.
"I appreciate the fact that [Walgreens is] trying to do some very good things with respect to clinical offerings and other avenues to try to impact the overall healthcare spectrum. But quite frankly, that hasn't been proven to reduce cost."
Walgreens Specialty Pharmacy on Thursday released data showing that both patients and their health plans can realize savings of up to 60% on the cost of infused specialty medications by choosing alternate treatment sites.
One year after launching a national awareness campaign focused on the benefits of 90-day prescription refills at retail pharmacies, Walgreens on Friday released new data supporting the success of the 90-day refill program and its overarching benefits to patients and payers.